Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Inhaled Nitric Oxide Delivery Systems Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21664

Download Sample Report
Published On

January 2022

Total pages

229

About the Report

Inhaled Nitric Oxide is a minimally invasive therapy that is used for the treatment of conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension. It is a selective pulmonary Vaso-dilator, which reduces pressures in the pulmonary artery and improves arterial oxygenation in infants and adults with respiratory failures.

The growing adoption of inhaled nitric oxide delivery systems can be attributed to the rising prevalence of various respiratory diseases. Some of the most common respiratory diseases include lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive pulmonary disease (COPD). Almost 3.3 million people succumb to COPD every year, as per the World Health Organization. Also, according to the American Cancer Society estimates, in the U.S., nearly 235,070 new cases of lung cancer and tumors were detected in 2018. This in turn is positively impacting the inhaled nitric oxide delivery systems market globally.

Furthermore, the inhaled nitric oxide delivery systems market is anticipated to grow on account of the growing adoption of the inhaled nitric oxide delivery systems and favorable government initiatives along with the expedited FDA approvals. For example, in January 2020, As per Vero Biotech LLC, the FDA has approved the Genosyl inhaled nitric oxide (iNO) gas delivery system. Genosyl is a tankless, portable iNO system that eliminates the need for large nitric oxide tanks. Furthermore, the advantages offered by inhaled nitric oxide and the use of iNO as an effective treatment against the SARS-CoV-2 virus are some of the other factors driving the market across the globe.

Based on type, the market is bifurcated into paediatrics and adults. The paediatrics segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027.

Based on applications, the market is segmented into hypoxic respiratory failure, acute hypoxemic respiratory failure, chronic obstructive pulmonary disease, and others. The hypoxic respiratory failure segment occupied the major share of the inhaled nitric oxide delivery systems market in 2020 and it is expected to grow with substantial CAGR in the forecast period.

Based on product type, the market is segmented into disposables and systems. The disposables segment grabbed XX% market share of the inhaled nitric oxide delivery systems market and gathered revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027.

Based on the end-users, the market is fragmented into hospital, ambulatory centers, and clinics. The hospital captured XX% market share in 2020. The market of this segment is expected to reach USD XX million by 2027.

For a better understanding of the market adoption of the Inhaled Nitric Oxide Delivery Systems, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is expected to grow rapidly for the inhaled nitric oxide delivery systems industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing adoption of advanced technological solutions in the healthcare industry in the region.

Some of the major players operating in the market are Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc., among others. Several M&A's along with partnerships have been undertaken by these players to develop new and advanced inhaled nitric oxide delivery systems.

The Global Inhaled Nitric Oxide Delivery Systems Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021 to 2027. The Inhaled Nitric Oxide Delivery Systems Market is expected to witness a boost, owing to the growing number of respiratory failure incidences and growing adoption of inhaled nitric oxide delivery systems.

Scope of the Report

Products

Inhaled Nitric Oxide is a minimally invasive therapy that is used for the treatment of conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension.

Companies

Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc.

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Inhaled Nitric Oxide Delivery Systems Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Inhaled Nitric Oxide Delivery Systems Market

2.1.1 Main Objective of the Global Inhaled Nitric Oxide Delivery Systems Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET REVENUE

7 MARKET INSIGHTS BY TYPE

7.1 Paediatrics

7.2 Adults

8 MARKET INSIGHTS BY APPLICATION

8.1 Hypoxic Respiratory Failure (HRF)

8.2 Acute Hypoxemic Respiratory Failure (AHRF)

8.3 Chronic Obstructive Pulmonary Disease (COPD)

8.4 Others

9 MARKET INSIGHTS BY PRODUCT TYPE

9.1 Disposables

9.2 System

10 MARKET INSIGHTS BY END-USERS

10.1 Hospital

10.2 Ambulatory Centers

10.3 Clinics

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 Rest of Asia Pacific

11.4 REST OF THE WORLD INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET

12 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET OPPORTUNITIES

14 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET TRENDS & INSIGHTS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1 Demand Side Analysis

16.2 Supply Side Analysis

16.2.1 Top Product Launches

16.2.2 Top Business Partnerships

16.2.3 Top Merger & Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Mallinckrodt Pharmaceuticals

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Mallinckrodt Pharmaceuticals

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Getinge

19.3 Vero Biotech

19.4 LINDE

19.5 Beyond Air

19.6 Air Liquide Healthcare

19.7 Circassia Pharmaceuticals

19.8 NU MED

19.9 Bellerophon Therapeutics

19.10 Praxair Technology Inc.

20 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022